hydroxychloroquine and cyclosporine

hydroxychloroquine has been researched along with cyclosporine in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (24.59)	18.2507
2000's	21 (34.43)	29.6817
2010's	16 (26.23)	24.3611
2020's	9 (14.75)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hill, JM; Tattersfield, AE	1
Moss, RB	1
Mehregan, DR; Su, WP	1
Carotti, M; Cervini, C; Salaffi, F	1
Beams, F; Gilman, AL; Mazumder, A; Tefft, M	1
Bader, S; Nelson, D; Schultz, KR	1
Spector, SL	1
Gilman, AL; Schultz, KR	1
Haagsma, CJ; van Riel, PL	1
Bader, S; HayGlass, KT; Nelson, D; Schultz, KR; Wang, MD	1
McCune, WJ; Singer, NG	1
O'Dell, JR	1
Casatta, L; Damato, R; De Vita, S; Di Poi, E; Falleti, E; Ferraccioli, G; Salaffi, F	1
Klassen, LW; Moore, GF; O'Dell, JR	1
Schattner, A	1
Cho, CS; Kim, HY; Kim, WU; Lee, SK; Lee, WK; Paek, SI; Park, SH; Seo, YI; Song, HH	1
Kremer, JM	1
O'Dell, J	1
Pisetsky, DS; St Clair, EW	1
Gross, WL; Schnabel, A	1
Petri, M	1
Førre, Ø; Haga, HJ; Johnsen, V; Kvien, TK; Mikkelsen, K; Nordvåg, BY; Rødevand, E	1
Alfieri, G; Atzeni, F; Beyene, NB; Cazzola, M; Chérié-Lignière, EL; Corbelli, V; D'Ingianna, E; Fiorentini, F; Fiorini, T; Fumagalli, M; Locati, M; Mastaglio, C; Menozzi, G; Monti, G; Panni, B; Saccardo, F; Sarzi-Puttini, P; Scarpellini, M; Severi, C	1
Airò, P; Biggioggero, M; Borghi, O; Cimaz, R; Meregalli, E; Meroni, PL; Motta, M; Tincani, A	1
Emery, P; Suarez-Almazor, M	1
Fath, R	1
Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A	1
Amital, H; Arnson, Y; Dovrish, Z; Hadari, R	1
Andersen, LS; Ellingsen, T; Hansen, GV; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M	1
Chirico, G; Ciardelli, L; Gasparoni, A; Lojacono, A; Marconi, M; Motta, M; Tincani, A	1
D'Angelo, S; Olivieri, I; Palazzi, C	1
Akkaya, AD; Göktay, F; Güneş, P; Mansur, AT; Masatlioğlu, SP	1
Allaart, CF; Dijkmans, BA; Huizinga, TW; Kerstens, PJ; Klarenbeek, NB	1
Di Lernia, V; Grenzi, L; Guareschi, E; Ricci, C	1
Lateef, A; Lau, TC; Tan, KB	1
Nguyen, JV; Sperling, LC	1
Brito, C; da Luz Duarte, M; Pardal, F; Ventura, F; Vilarinho, C	1
Brown, DC; Casal, ML; Mauldin, EA; Morris, DO	1
Balbir-Gurman, A; Bergman, R; Braun-Moscovici, Y; Egozi, D; Markovits, D; Melamed, Y; Ramon, Y; Rozin, AP; Schapira, D; Toledano, K; Ullman, Y	1
Fourie, J; McEachen, SC; van Heerden, WF; van Zyl, A	1
Miller, AV; Ranatunga, SK	1
Bové, A; Brito-Zerón, P; Kostov, BA; Ramos-Casals, M; Sisó-Almirall, A	1
D'Amico, E; D'Angelo, S; Gilio, M; Leccese, P; Olivieri, I; Palazzi, C	1
Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D	1
Chang, YT; Chen, CC; Chen, DY; Chen, YJ; Ho, HJ; Kuo, KN; Liu, HN; Shen, JL; Wu, CY	1
Anelli, MG; Cacciapaglia, F; Covelli, M; Iannone, F; Lapadula, G; Rinaldi, A; Scioscia, C; Serafino, L	1
Chen, CJ; Cheng, TT; Lin, JC; Lin, KM	1
Guo, C; Wu, R; Zheng, N	1
Castner, NB; Harris, JC; Motaparthi, K	1
Gieler, U; Husein-ElAhmed, H; Steinhoff, M	1
Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ	1
Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M	1
Bombardieri, S; Bootsma, H; Bowman, S; Brito-Zerón, P; De Vita, S; Dörner, T; Fisher, BA; Gottenberg, JE; Hernandez-Molina, G; Kocher, A; Kostov, B; Kruize, AA; Mandl, T; Mariette, X; Ng, WF; Ramos-Casals, M; Retamozo, S; Seror, R; Shoenfeld, Y; Sisó-Almirall, A; Tzioufas, AG; Vitali, C	1
Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G	1
Hammad, I; Porter, TF	1
Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C	1
Al-Obaidi, M; Ciurtin, C; Doolan, G; Faizal, NM; Foley, C; Jury, EC; Lieberman, SM; Price, E; Ramanan, AV	1
Arava, S; Baskaran, N; Gupta, S; Mehta, N	1
An, Y; Li, R; Wang, H; Zhang, C	1

Reviews

24 review(s) available for hydroxychloroquine and cyclosporine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Corticosteroid sparing agents in asthma. Thorax, 1995, Volume: 50, Issue:5 Topics: Adrenal Cortex Hormones; Asthma; Cyclosporine; Gold; Humans; Hydroxychloroquine; Methotrexate	1995
Alternative pharmacotherapies for steroid-dependent asthma. Chest, 1995, Volume: 107, Issue:3 Topics: Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclosporine; Dapsone; Furosemide; Gold; Humans; Hydroxychloroquine; Magnesium Sulfate; Methotrexate; Treatment Outcome; Troleandomycin	1995
Alternative treatments in the patient with intractable asthma. Current opinion in pulmonary medicine, 1997, Volume: 3, Issue:1 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Asthma; Cyclosporine; Dapsone; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Organogold Compounds; SRS-A; Troleandomycin	1997
The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease. Leukemia & lymphoma, 1997, Volume: 24, Issue:3-4 Topics: Animals; Antigen Presentation; Bone Marrow Transplantation; Chloroquine; Clinical Trials as Topic; Cyclosporine; Drug Synergism; Graft vs Host Disease; H-2 Antigens; Histocompatibility Antigens Class II; HLA Antigens; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoantigens; Lysosomes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes, Cytotoxic	1997
Combination of second-line antirheumatic drugs. Annals of medicine, 1997, Volume: 29, Issue:2 Topics: Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome	1997
Update on immunosuppressive therapy. Current opinion in rheumatology, 1998, Volume: 10, Issue:3 Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide	1998
Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis. Rheumatic diseases clinics of North America, 1998, Volume: 24, Issue:3 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome	1998
Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Annals of internal medicine, 2001, Apr-17, Volume: 134, Issue:8 Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Costs; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Factors; Sulfasalazine	2001
Progress in the treatment of rheumatoid arthritis. JAMA, 2001, Dec-12, Volume: 286, Issue:22 Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine	2001
Immunosuppressive drug use in pregnancy. Autoimmunity, 2003, Volume: 36, Issue:1 Topics: Adrenal Cortex Hormones; Azathioprine; Breast Feeding; Cyclophosphamide; Cyclosporine; Female; Fetal Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maternal-Fetal Exchange; Mycophenolic Acid; Pregnancy; Pregnancy Complications	2003
[Combination therapy in rheumatoid arthritis]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2003, May-29, Volume: 123, Issue:11 Topics: Adjuvants, Immunologic; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine	2003
Rheumatoid arthritis. Clinical evidence, 2003, Issue:9 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine	2003
Hepatitis C virus-related arthritis. Autoimmunity reviews, 2008, Volume: 8, Issue:1 Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rheumatoid; Chronic Disease; Cryoglobulinemia; Cyclooxygenase 2 Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Hydroxychloroquine; Interferon-alpha; Methotrexate; Penicillamine; Purpura	2008
The BeSt story: on strategy trials in rheumatoid arthritis. Current opinion in rheumatology, 2009, Volume: 21, Issue:3 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Infliximab; Methotrexate; Prednisolone; Sulfasalazine	2009
Chronic ulcerative stomatitis: a distinct clinical entity? SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging, 2011, Volume: 66, Issue:3 Topics: Adult; Antirheumatic Agents; Chronic Disease; Cyclosporine; Diagnosis, Differential; Female; Gingivitis, Necrotizing Ulcerative; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus, Oral; Mouth Mucosa; Skin Ulcer; South Africa	2011
Immunotherapies in rheumatologic disorders. The Medical clinics of North America, 2012, Volume: 96, Issue:3 Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors	2012
Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:3 Topics: Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Molecular Targeted Therapy; Ophthalmic Solutions; Saliva, Artificial; Sjogren's Syndrome	2013
An update on the management of hepatitis C virus-related arthritis. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:14 Topics: Antirheumatic Agents; Antiviral Agents; Arthritis; Autoimmune Diseases; Cyclosporine; Disease Management; Drug Therapy, Combination; Hepacivirus; Humans; Hydroxychloroquine; Interferon-alpha; Ribavirin; Tumor Necrosis Factor-alpha	2014
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine. Dermatologic therapy, 2018, Volume: 31, Issue:5 Topics: Acute Generalized Exanthematous Pustulosis; Cyclosporine; Dermatologic Agents; Female; Glucocorticoids; Humans; Hydroxychloroquine; Methylprednisolone; Middle Aged; Prednisone; Retreatment	2018
Lichen planus: a comprehensive evidence-based analysis of medical treatment. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:10 Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy	2019
An Update on Biologic Agents During Pregnancy. Clinics in perinatology, 2020, Volume: 47, Issue:4 Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors	2020
Interventions for cutaneous disease in systemic lupus erythematosus. The Cochrane database of systematic reviews, 2021, 03-09, Volume: 3 Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up	2021
Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature. Rheumatology (Oxford, England), 2022, 03-02, Volume: 61, Issue:3 Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Rituximab; Sjogren's Syndrome	2022

Trials

7 trial(s) available for hydroxychloroquine and cyclosporine

Article	Year
Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis. Scandinavian journal of rheumatology, 1996, Volume: 25, Issue:1 Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Treatment Outcome	1996
Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy. The Journal of rheumatology, 1998, Volume: 25, Issue:10 Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxychloroquine; Immunoglobulins; Interleukin-10; Interleukins; Male; Middle Aged	1998
Treatment with cyclosporin switching to hydroxychloroquine in patients with rheumatoid arthritis. Annals of the rheumatic diseases, 2001, Volume: 60, Issue:5 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Hydroxychloroquine; Hypertension; Hypertrichosis; Linear Models; Male; Methotrexate; Middle Aged; Pilot Projects; Treatment Outcome	2001
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis. Rheumatology international, 2005, Volume: 25, Issue:1 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pain Measurement; Severity of Illness Index; Treatment Outcome	2005
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Annals of the rheumatic diseases, 2008, Volume: 67, Issue:6 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Betamethasone; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome	2008
Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment. Veterinary dermatology, 2010, Volume: 21, Issue:4 Topics: Adalimumab; Animals; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cyclosporine; Dog Diseases; Dogs; Fatty Acids; Female; Genetic Predisposition to Disease; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male	2010
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response. Drug development research, 2014, Volume: 75 Suppl 1 Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Certolizumab Pegol; Cholesterol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Lipid Metabolism; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha	2014

Other Studies

30 other study(ies) available for hydroxychloroquine and cyclosporine

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cyclosporine treatment for dermatomyositis/polymyositis. Cutis, 1993, Volume: 51, Issue:1 Topics: Azathioprine; Cyclosporine; Dermatomyositis; Female; Humans; Hydroxychloroquine; Middle Aged; Polymyositis; Prednisone; Quinacrine	1993
The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease. Bone marrow transplantation, 1996, Volume: 17, Issue:6 Topics: Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Humans; Hydroxychloroquine; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; T-Lymphocytes; Tumor Necrosis Factor-alpha	1996
Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous protein antigen, tetanus toxoid. Bone marrow transplantation, 1996, Volume: 18, Issue:3 Topics: Adult; Antigens, Differentiation, B-Lymphocyte; Chloroquine; Cyclosporine; Drug Synergism; Graft vs Host Disease; Histocompatibility Antigens Class II; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lymphocyte Activation; T-Lymphocytes; Tetanus Toxoid	1996
Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist? Transplantation, 1997, Oct-15, Volume: 64, Issue:7 Topics: Animals; Cell Survival; Cells, Cultured; Chloroquine; Concanavalin A; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Histocompatibility Antigens Class II; Hydroxychloroquine; Interferon-gamma; Interleukin-2; Kinetics; Lymphocyte Activation; Lysosomes; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Minor Histocompatibility Antigens; Spleen; T-Lymphocytes	1997
Combination therapy in rheumatoid arthritis: a comment. Rheumatology (Oxford, England), 1999, Volume: 38, Issue:6 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome	1999
Treatment considerations in early rheumatoid arthritis. Journal of internal medicine, 1997, Volume: 241, Issue:6 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Patient Selection; Risk; Sulfasalazine; Time Factors; Treatment Outcome	1997
Conventional DMARD options for patients with a suboptimal response to methotrexate. The Journal of rheumatology. Supplement, 2001, Volume: 62 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine	2001
[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents]. Deutsche medizinische Wochenschrift (1946), 2003, Jan-24, Volume: 128, Issue:4 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors	2003
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Toxicology letters, 2004, Apr-01, Volume: 149, Issue:1-3 Topics: Adult; Aspirin; Autoimmune Diseases; Azathioprine; Cyclosporine; Dexamethasone; Female; Hemoglobins; Hepatitis Antibodies; Hepatitis B Vaccines; Humans; Hydroxychloroquine; Immune System; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Leukocyte Count; Lymphocyte Count; Male; Platelet Count; Prednisone; Pregnancy; Vaccination	2004
[When to begin rheumatism treatment? Initial combination therapy helps fastest]. MMW Fortschritte der Medizin, 2004, Sep-09, Volume: 146, Issue:37 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2004
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis. Clinical rheumatology, 2007, Volume: 26, Issue:7 Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure	2007
Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis. The Israel Medical Association journal : IMAJ, 2007, Volume: 9, Issue:6 Topics: Adult; Arthralgia; Cyclosporine; Dermatologic Agents; Dermatomyositis; Exanthema; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Prednisone	2007
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents. American journal of perinatology, 2007, Volume: 24, Issue:8 Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Female; Humans; Hydroxychloroquine; Immune System; Immunoglobulin Isotypes; Immunophenotyping; Immunosuppressive Agents; Infant; Infant, Newborn; Leukocytes, Mononuclear; Lymphocyte Count; Lymphocyte Subsets; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies	2007
Systemic lupus erythematosus presenting as pyoderma gangrenosum in two cases. Rheumatology international, 2009, Volume: 29, Issue:7 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antiphospholipid; Cicatrix, Hypertrophic; Cyclosporine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Pyoderma Gangrenosum; Skin; Treatment Outcome; Ulcer	2009
Rapid clearing of acute generalized exanthematous pustulosis after administration of ciclosporin. Clinical and experimental dermatology, 2009, Volume: 34, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Middle Aged; Skin Diseases, Vesiculobullous; Treatment Outcome	2009
Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine. Clinical rheumatology, 2009, Volume: 28, Issue:12 Topics: Aged; Antirheumatic Agents; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Skin Diseases, Vesiculobullous; Stevens-Johnson Syndrome; Treatment Outcome	2009
Commentary: treatment of lichen planopilaris: some progress, but a long way to go. Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:3 Topics: Adrenal Cortex Hormones; Alopecia; Clinical Trials as Topic; Cyclosporine; Female; Humans; Hydroxychloroquine; Lichen Planus; Male; Scalp Dermatoses; Severity of Illness Index	2010
Two cases of annular elastolytic giant cell granuloma: Different response to the treatment. Dermatology online journal, 2010, Mar-15, Volume: 16, Issue:3 Topics: Aged; Anti-Inflammatory Agents; Betamethasone; Cyclosporine; Female; Granuloma Annulare; Granuloma, Giant Cell; Humans; Hydroxychloroquine; Male; PUVA Therapy	2010
Large leg ulcers due to autoimmune diseases. Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:1 Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; Cyclosporine; Female; Humans; Hydroxychloroquine; Hyperbaric Oxygenation; Infliximab; Larva; Leg Ulcer; Male; Methylprednisolone; Middle Aged; Prednisolone; Skin Transplantation; Treatment Outcome; Vancomycin; Vasculitis; Young Adult	2011
Psoriatic arthritis treatment and the risk of herpes zoster. Annals of the rheumatic diseases, 2016, Volume: 75, Issue:1 Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha	2016
The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study. Arthritis research & therapy, 2014, Sep-30, Volume: 16, Issue:5 Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Asian People; Cohort Studies; Cyclosporine; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Incidence; Insurance; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasms; Outcome Assessment, Health Care; Proportional Hazards Models; Receptors, Tumor Necrosis Factor; Risk Factors; Taiwan; Tumor Necrosis Factor-alpha	2014
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. Clinical rheumatology, 2015, Volume: 34, Issue:6 Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha	2015
Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone. Scandinavian journal of rheumatology, 2018, Volume: 47, Issue:5 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Sulfonamides; Treatment Outcome	2018
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study. Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7 Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors	2020
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission. Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7 Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors	2020
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:1 Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lubricant Eye Drops; Muscarinic Agonists; Saliva, Artificial; Sjogren's Syndrome	2020
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine	2020
B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus. BMJ case reports, 2022, May-27, Volume: 15, Issue:5 Topics: Chilblains; Cyclosporine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Rituximab	2022
Breastfeeding by a mother taking cyclosporine for nephrotic syndrome. International breastfeeding journal, 2022, 10-17, Volume: 17, Issue:1 Topics: Adult; Breast Feeding; Cyclosporine; Female; Humans; Hydroxychloroquine; Infant; Mothers; Nephrotic Syndrome; Prednisone; Pregnancy	2022